Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.3 / 5 stars · 56/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.40% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-07-23

  • WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.40%, a 0.00% change year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.40%, a 33.33% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.30%, a 0.00% change year-over-year.
  • WEST PHARMACEUTICAL SERVICES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.30%, a 50.00% increase year-over-year.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month
2026-06-300.40%
10-Q · filed 2026-07-23
2026-03-310.40%
10-Q · filed 2026-04-23
2025-09-300.40%
10-Q · filed 2025-10-23
2025-06-300.40%
10-Q · filed 2025-07-24
2025-03-310.40%
10-Q · filed 2025-04-24
2024-09-300.30%
10-Q · filed 2024-10-24
2024-06-300.30%
10-Q · filed 2024-07-25
2024-03-310.30%
10-Q · filed 2024-04-25
2023-09-300.30%
10-Q · filed 2023-10-26
2023-06-300.30%
10-Q · filed 2023-07-27
2023-03-310.30%
10-Q · filed 2023-04-27
2022-09-300.20%
10-Q · filed 2022-10-27
2022-06-300.20%
10-Q · filed 2022-07-28
2022-03-310.20%
10-Q · filed 2022-04-28
2021-09-300.30%
10-Q · filed 2021-10-28
2021-06-300.30%
10-Q · filed 2021-07-30
2021-03-310.30%
10-Q · filed 2021-04-30
2020-09-300.40%
10-Q · filed 2020-10-23
2020-06-300.40%
10-Q · filed 2020-07-24
2020-03-310.40%
10-Q · filed 2020-04-24
2019-09-300.70%
10-Q · filed 2019-10-29
2019-06-300.70%
10-Q · filed 2019-07-29
2019-03-310.70%
10-Q · filed 2019-05-08
2018-09-300.70%
10-Q · filed 2018-10-30
2018-06-300.70%
10-Q · filed 2018-07-31
2018-03-310.70%
10-Q · filed 2018-05-08
2017-09-300.70%
10-Q · filed 2017-10-31
2017-06-300.70%
10-Q · filed 2017-08-01
2017-03-310.70%
10-Q · filed 2017-05-05
2016-09-301.00%
10-Q · filed 2016-10-31
2016-06-301.00%
10-Q · filed 2016-08-01
2016-03-310.90%
10-Q · filed 2016-05-06
2015-09-300.90%
10-Q · filed 2015-11-02
2015-06-300.90%
10-Q · filed 2015-08-03
2015-03-311.00%
10-Q · filed 2015-05-06
2014-09-300.80%
10-Q · filed 2014-11-03
2014-06-300.80%
10-Q · filed 2014-08-01
2014-03-310.80%
10-Q · filed 2014-05-08
2013-09-301.30%
10-Q · filed 2013-11-04
2013-06-301.30%
10-Q · filed 2013-08-05
2013-03-311.30%
10-Q · filed 2013-05-06
2012-09-301.70%
10-Q · filed 2012-11-05
2012-03-311.70%
10-Q · filed 2012-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44